Baiyun mountain and yellow spending one hundred million yuan more traditional medicine research and development of high quality Chinese medicine or preferred brand 
 
 
May 8, 2015 
 
 

Source: xinhua tianjin channel 

    Xinhuanet tianjin on May 8 on May 5, the national development and reform commission and national health family planning, human resources and social security ministry and other departments issued "opinions to push forward the reform of drug prices" (hereinafter referred to as "opinions"), from June 1, 2015 to cancel the vast majority of drug pricing, government establish take the market as the leading drug price forming mechanism. China medical university, director of the institute pharmaceutical price Chang Feng thinks, after let go of drug pricing better curative effect for low prices, proprietary Chinese medicine is a kind of good. The broad medicine baiyun mountain will invest 1.5 billion yuan to wide medicine group multiple enterprise r&d platform construction and r&d spending, including on famous traditional secondary development in the field of traditional Chinese medicine (TCM), and the evaluation of the listed again after, all kinds of chemical drugs and all kinds of nutrition and health products research and development, etc.
 
    Baiyun mountain and yellow again spent one hundred million yuan increase in baiyun mountain, radix isatidis, the effect of the traditional medicine research and development
 
    Have baiyun mountain, radix isatidis, baiyun mountain effect, baiyun mountain is phlogistic, baiyun mountain antiphlogistic cholagogue pieces and a number of famous traditional products well-known pharmaceutical companies - baiyun mountain and yellow is widely medicine group, one of backbone enterprises. Start in January 2015, the broad medicine baiyun mountain billions financing plan, hand in hand to jack ma, a strategic partner. Jack ma, founder and mass media YuFeng co-founded yunfeng capital invested 500 million yuan to become a shareholder in the broad medicine baiyun mountain.
 
    As the backbone of the broad medicine group enterprise, is one of the largest single Chinese medicine manufacturing enterprise in south China the baiyun mountain and Huang Zhong medicine, will be spent one hundred million yuan increase in radix isatidis, the effect of secondary development and upgrading of traditional medicine. In may last year, this is the baiyun mountain and Huang Zhong drug "spend 1 billion yuan expansion of baiyun mountain effect, baiyun mountain, radix isatidis products such as the GAP planting base of raw materials and GMP production workshop, to ensure that a few" brand products are able to supply with good quality and ensuring market policy after another big move, for people to produce big brand, high quality, reasonable price, good medicine, to ensure that in similar products in the market share for the first brand products are able to supply with good quality and ensuring market, greatly ease the people use your problem.
 
    "Some drug pricing is, in fact, many years ago, before there is profit space, but it's more than a decade has gone up a lot of Chinese medicinal materials cost, labor costs are rising, so will form the selling price. Now let go of the restrictions, can solve the problem of cost and price upside down." China pharmaceutical university international medical school of medicine prices expert, medicine research institute Chang Feng pointed out that drug price return to the market for new drug research and development is also a good news, because companies have a good psychological expectations, know development is profitable, then will put money to put into research and development.
 
    Baiyun mountain and yellow to increase product supply Ordinary drugs or have more choice
 
    A series of drug price reform policies, the development of drug firms and for the development of medical technology and innovation play a positive role. On the one hand, make traditional Chinese medicine brand enterprises can do more promotion, increase the consumer's perception of TCM products. On the other hand also let Chinese medicine enterprises have dynamic space and increase investment in scientific research, promote Chinese medicine science and technology products research and development, to do well in traditional Chinese medicine products. In recent years, the baiyun mountain and yellow to "scientific and technological innovation" as one of the important development of the enterprise strategy, increasing research investment, actively promote the secondary development and upgrading of traditional Chinese medicine products.
 
    The commonly used traditional Chinese medicine to treat disease of heart head blood-vessel, the market share first of baiyun mountain the effect, for example, in recent years, increasing research investment, the product has won the prevention and treatment of alzheimer's patents of quality control, fingerprint technology, effective ingredient ratio of science such as patents. Especially in the aspects of science and technology and the "father" of viagra, Nobel Prize winner, the famous American physician Philip reed, Dr Murad collaboration "nitric oxide is used for research on prevention and control of baiyun mountain the effect mechanism of heart head blood-vessel, the baiyun mountain effect research on the mechanism of the prevention and treatment of alzheimer's research project. In addition, on the secondary development of the effect, discovered the baiyun mountain effect can also be used to prevent or treat diabetic retinopathy, diabetic nephropathy and diabetic neuropathy, diabetic complications.
 
    Baiyun mountain of radix isatidis is baiyun mountain and Huang Zhong medicine another star products, is also the first major brands of radix isatidis products. Baiyun mountain radix isatidis particle research team, led by academician zhong nanshan, founded in 2011 by guangzhou medical university and macau university of science and technology, the broad medicine baiyun mountain group jointly established the "way of respiratory pathogens joint research center", by way of long-term cooperation mechanism to scroll to promote basic and clinical research of radix isatidis. Joint research team introduced international advanced "evidence-based medicine" and the concept of "systems biology", radix isatidis on comprehensive evidence-based clinical and basic research, the study found that baiyun mountain radix isatidis antiviral function embodies the traditional Chinese medicine for the characteristics of targets, multi-channel synergy. In addition, in the baiyun mountain antiviral compounds containing indole compounds of radix isatidis research shows that baiyun mountain antiviral component in the radix isatidis particle has great potential for further research and development of new drugs.
 
    Baiyun mountain is phlogistic baiyun mountain and Huang Zhong drug particles are independent only internal and varieties of proprietary Chinese medicine in the development of the prevention and treatment of oral ulcer. Products on the production technology innovation, "white cloud mountain is phlogistic particle fingerprint study" in 2010 through the identification of scientific and technological achievements, at present has made "the treatment of chronic pharyngitis patent", "patent of fingerprint quality control", "treatment of oral cavity inflammation patent" and so on a number of patents, ensures the quality of the product advantages, reached the domestic same industry leading level. Recently, baiyun mountain is also in line with the Huang Zhong medicine research institute is phlogistic qing drug particles for child safety research, conducted stomatitis clear grain fo his o treating children recurrent ulcer (Yin deficiency syndrome) fire Ⅳ phase of clinical trial, preliminary analysis results showed that the curative effect o stomatitis qing can effectively treat children recurrent he had ulcer.
 
    Baiyun mountain and yellow on the research of increasing investment and secondary development not only promote the baiyun mountain effect, baiyun mountain, radix isatidis, baiyun mountain pass the curative effect of qing grain products such as promotion, inject new connotation to the development of the traditional classical medicine, new energy, won the people's cognition and recognition. After the upgrading of the classic good medicine will be more get the favour of consumers, promote the great development of the traditional Chinese medicine market.
 
    Now, cancel the vast majority of drug pricing "government policies issued, baiyun mountain and yellow is also the first time a positive response, in addition to spend one hundred million yuan to increase investment in scientific research and the secondary development of products, also plans to increase the production of more than ten kinds of classical medicine, such as bolus of 6 flavour glutinous rehmannia, orange phlegm cough Fried paste, cough loquat particles, such as drug to ensure that people have more options, use high quality brand of medicine.
 
    Most of the drugs to cancel the government pricing high quality brand medicine is preferred
 
    Li Chuyuan, one of the broad medicine group chairman, said the broad medicine group has more than 2000 drug approval, but there are quite a few are no production, this is because the price of some drugs with price upside down, lead to many big brand cheap medicine can't production. Today, there are more like baiyun mountain and Huang Zhong medicine famous brand enterprises will increase some classical medicine production supply, companies can develop their own according to pharmaceutical production cost and market supply and demand or adjust the retail price, to ensure reasonable profits. For this reason, some cheap medicine market will recover, allowing people to have more autonomy and choice.
 
    For the release of the national drug pricing policy, some experts believe that on the one hand, the price can let go of to a certain extent, reduce the vicious bidding the disadvantages of "low price is only take", ease some cheap medicine market supply shortage; On the other hand, through the improvement of the mechanism of drug purchase and payment health-care reform, play to the rational use of drugs, the reasonable diagnosis and treatment of medical institutions internal incentives, could prompt pharmaceuticals market "bad drive out bad money," the quality is poor, prices artificially high drug from the market. 
 
    According to media reports, in recent years, as the raw materials, artificial, logistics and other costs rise, some cheap medicine approach for production cost, some even more than for inversion phenomenon, firms have to slow or stop production. Baiyun mountain and yellow production of baiyun mountain antiphlogistic cholagogue sales of nearly one hundred million yuan in 2012, the price is low, the population is very broad. But due to the cost problem, the company is totally at a loss. Baiyun mountain and Huang Zhong drugs while in qingyuan, guangdong taishan GAP planting base of medicinal materials is established, using the world's most advanced efficient thin film coating materials, using dual-frequency ultrasound extraction technology, fingerprint technology to control the product quality, for such a mature variety, if prices don't let go, the company can only slowly to give up the market supply of the product. Baiyun mountain for ordinary antiphlogistic cholagogue piece is a high technology content, using safely, effectively, the price also cheap courage to commonly, if exit the market is very regrettable. Now after drug price policy, the principal of the company said it would increase the production of the product and market supply, will increase to more than 10 kinds of classic medicine production, to ensure that people have more choices, using high quality branded, promote the future development of Chinese medicine market. (Yu Ying)